secwatch.observer — SEC 8-K summary
======================================

Issuer:     Microbot Medical Inc. (MBOT)
CIK:        0000883975
Form:       8-K
Filed at:   2025-08-20T23:59:59+00:00
Accession:  0001641172-25-024927
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Microbot Medical granted USPTO patent expanding LIBERTY system TAM to 6M+ US procedures
--------------------------------------------------------------------------------

- Patent covers modular robotic system with interchangeable tool-receiver units attachable to base.
- IP portfolio now: 12 patents granted globally, 57 patent applications pending.
- Enables future adaptation for wider endovascular procedures; US TAM could grow from 2.5M to 6M+ annual procedures.
- Company continues commercial readiness plans for LIBERTY system while awaiting FDA 510(k) clearance.
- CEO Harel Gadot: near-term focus remains on peripheral market and commercial readiness.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/883975/000164117225024927/0001641172-25-024927-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/883975/000164117225024927/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-024927

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer